Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Conatus Pharmaceuticals Inc.

NASDAQ: CNATHealthcare / Biotechnology / USA
1.56-0.0500-3.11%Vol 258 1541Y Perf -63.89%
Dec 13th, 2018 10:29
BID1.55 ASK1.57
Open1.65 Previous Close1.61
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.00 
Analyst Rating
Strong Buy 1.40
Potencial %
674.19 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
     38.18
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     39.89
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)47 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.08 
Earnings Date
1st Nov 2018

Today's Price Range

1.551.65

 

52wk Range

1.497.95

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-67.01%
3 Months
-64.85%
6 Months
-68.68%
1 Year
-63.89%
3 Years
-41.88%
5 Years
-73.17%

Quotes

Name / TickerPriceChg.Chg.%
CNAT1.56-0.0500-3.11
AAPL171.732.63001.56
GOOG1 071.998.31000.78
MSFT109.870.79000.72
XOM76.730.71000.93
WFC47.49-0.2500-0.52
JNJ148.080.98000.67
FB144.850.35000.24
GE7.420.710010.58
JPM101.280.26000.26
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.30
Current Ratio
2.40
Long Term Debt to Total Capital
0.45
Total Debt to Equity
0.83
Interest Coverage
-23.60
Leverage Ratio 3.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-50.60
EBITDA Margin
-50.30
Pre-tax Profit Margin
-
Profit Margin
-52.77
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
3.41
PS Ratios
1.62
Price to Cash Flow
6.70
Price to Free Cash Flow
-1.60
Cash Flow Per Share
-1.20
Price to Tangible Book
3.41
Book Value per Share
0.50
Enterprise Value (in ths.)
20 774
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-81.25
ROE last 12 Months
-77.08
Return on Assets (5Y Avg)
-28.11
ROA last 12 Months
-25.05
Return on Capital (5Y Avg)
-55.26
ROC last 12 Months
-50.10
Return on invested Capital Q
-14.58
Return on invested Capital Y
-46.32
Assets Turnover
0.20
Receivables Turnover
5.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
34 981
Revenue per Share
1.06
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.15-0.150.00
Q02 2018-0.20-0.1525.00
Q01 2018-0.17-0.170.00
Q04 2017-0.17-0.1511.76
Q03 2017-0.05-0.13-160.00
Q02 2017-0.11-0.19-72.73
Q01 2017-0.14-0.140.00
Q04 2016-0.32-0.35-9.38
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.156.25Positive
12/2018 FY-0.610.00-
3/2019 QR-0.1343.48Positive
12/2019 FY-0.1715.00Positive
Next Report Date-
Estimated EPS Next Report-0.15
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume258 154
Shares Outstanding (in ths.)30 260
Trades Count493
Dollar Volume387 215
Avg. Volume659 153
Avg. Weekly Volume1 504 189
Avg. Monthly Volume1 110 822
Avg. Quarterly Volume889 071

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

61%39%

Bearish Bullish

58%42%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
5 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News